Difference between revisions of "Team:NCTU Formosa/Acheivement"

Line 137: Line 137:
 
<div class="content">
 
<div class="content">
 
     <ul type=disc  style="text-align:justify;" >
 
     <ul type=disc  style="text-align:justify;" >
<li>We created the fluorescent E.Cotectors with the single chain variable fragment (scFv) of monoclonal antibody used on targeted therapies on its outer membrane.
+
<li>Cotramsforming Biobricks for creating Customized Detection Platform
<li>We created our E.Cotectors with the gold binding peptide (GBP) on its outer membrane.  
+
<li>We built three type of biobrick libraries: scFv , color signal and GBP to display on E.coli’s outer membrane for creating customized detection platform.
<li>We created the different colors of fluorescent E.Cotectors with different scFv of monoclonal antibodies.
+
<li>With cotransformation, we offered several of customized combinations, such as E.Cotector with different scFv of targeted drugs and different color signal or with GBP.
<li>We proved that the scFv have binding specificity and our E.Cotectors can bind to antigens to distinguish antigens overexpressed in cells.
+
<li>We proved that the binding specificity of E.Cotectors by our cell staining experiment and that suggest the scFv have successfully displayed on the surface of E.coli.
<li>We proved that our E.Cotectors can apply on different techniques of cell staining.
+
<li>Our E.Cotector succeeded in displaying GBP on the surface and binding on gold chip.
<li>We proved that the GBP can let our E.Cotectors adhere to the gold surface.
+
<li>We combined the Quartz crystal microbalance (QCM) technique with our E.Cotectors to measure the concentration of antigens.
+
 
</ul>
 
</ul>
 
<br>
 
<br>
Line 152: Line 150:
 
<ul type=disc  style="text-align:justify;" >
 
<ul type=disc  style="text-align:justify;" >
 
<li>We constructed 25 biobricks and conducted a series of experiments to verify their functions.
 
<li>We constructed 25 biobricks and conducted a series of experiments to verify their functions.
<li>We constructed the models to calculate the optimized environment for the highest binding affinity.
 
 
<li>We designed the mechanism to guarantee the safety on the gene level and the microorganism level.
 
<li>We designed the mechanism to guarantee the safety on the gene level and the microorganism level.
<li>We promoted the communication and the cooperation among various professional fields such as synthetic biology, measurement technology, immunology, and medical science via the participation in iGEM and the accomplishment of the project.
+
<li>To make our safety mechanism be more complete, we found out the optimal way to process and the best condition for conserving fluoresce proteins by modeling.
 +
<li>With our modeling, we realized how E.Cotector would grow and the condition of protein displaying.
 +
<li>Consulting with law expert to realize the law we should notice for our E.Cotector.
 +
<li>We introduced our ideas to doctors and asked some questions for us to realize problems and values of our project.
 +
<li>We introduced our ideas to Biotech company- ApexBio and asked some questions for us to realize problems and values of our project.
 +
<li>We designed a survey for public to recognize the pre-diagnosis of targeted drugs treatment.
 +
<li>We held “Be bald” activity for public to know more about the crucial of the pre-diagnosis of cancer treatments and also introduced iGEM with them during the activity.
 +
<li>Visiting the recovery cancer patient made us more realize the patient’s realistic circumstance and the importance of health.
 +
<li>HSNU iGEM team and Mingdo iGEM team was helped by us to continue commitment to their Pro
 +
<li>We held iGEM Asia Conference for 27 teams to meetup, exchange ideas, make friends and cooperate mutually.
 +
<li>We promoted the communication and the cooperation among various rofessional fields such as synthetic biology, measurement technology, immunology, and medical science via the participation in iGEM and the accomplishment of the project.
 
</ul>
 
</ul>
 
<br>
 
<br>
Line 162: Line 169:
 
<div class="content">
 
<div class="content">
 
<ul type=disc  style="text-align:justify;" >
 
<ul type=disc  style="text-align:justify;" >
<li>Simultaneously detected the multiple antigens.
+
<li>Simultaneously detected the multiple antigens.  
<li>Enlarged the signal of targeted antigens.
+
<li>For more quantitative data and more application on precise measurements, we testified the function of GBP to bind on gold with the concept of Biosensor.
<li>Combined the antigen measurement technique with others technique, enhanced the precision, and expanded its application.
+
<li>Enhanced the process yield in immobilization of antibodies on the medium gold surface.  
<li>Enhanced the process yield in immobilization of antibodies on the medium gold surface.
+
<li>The cost of using our E.cotectors is lower than using monoclonal antibodies targeted drugs directly on measuring antigens.  
<li>The cost of using our E.cotectors is lower than using monoclonal antibodies targeted drugs directly on measuring antigens.
+
 
 
</ul>
 
</ul>
 
<br>
 
<br>
Line 174: Line 181:
 
<p></p>
 
<p></p>
 
<ul type=disc  style="text-align:justify;" >
 
<ul type=disc  style="text-align:justify;" >
<li>Offer a new way to let doctors have more selections to make diagnosis.
+
<li>Offer a brand new direct method for doctors to determining the usage of monoclonal-antibody-targeted drugs.
<li>Directly used the antibody fragment of monoclonal antibody used on targeted therapy to distinguish antigens overexpressed in cells. Provided prescription of combination, personalized, and effective targeted drugs.
+
<li>Directly used the monoclonal-antibody-targeted-drugs to detect the corresponding antigen on the cancer cells.
<li>Prepared for the new era of medical digitalization.
+
<li>Provided a direct, personalized and customized pre-diagnosis of targeted drugs treatment detection platform.  
 +
<li>Offer the prescription of combination therapy to doctors.  
 +
 
 +
 
 
</ul>
 
</ul>
 
<br>
 
<br>

Revision as of 00:31, 10 September 2015

Acheivement

  • Cotramsforming Biobricks for creating Customized Detection Platform
  • We built three type of biobrick libraries: scFv , color signal and GBP to display on E.coli’s outer membrane for creating customized detection platform.
  • With cotransformation, we offered several of customized combinations, such as E.Cotector with different scFv of targeted drugs and different color signal or with GBP.
  • We proved that the binding specificity of E.Cotectors by our cell staining experiment and that suggest the scFv have successfully displayed on the surface of E.coli.
  • Our E.Cotector succeeded in displaying GBP on the surface and binding on gold chip.

  • We constructed 25 biobricks and conducted a series of experiments to verify their functions.
  • We designed the mechanism to guarantee the safety on the gene level and the microorganism level.
  • To make our safety mechanism be more complete, we found out the optimal way to process and the best condition for conserving fluoresce proteins by modeling.
  • With our modeling, we realized how E.Cotector would grow and the condition of protein displaying.
  • Consulting with law expert to realize the law we should notice for our E.Cotector.
  • We introduced our ideas to doctors and asked some questions for us to realize problems and values of our project.
  • We introduced our ideas to Biotech company- ApexBio and asked some questions for us to realize problems and values of our project.
  • We designed a survey for public to recognize the pre-diagnosis of targeted drugs treatment.
  • We held “Be bald” activity for public to know more about the crucial of the pre-diagnosis of cancer treatments and also introduced iGEM with them during the activity.
  • Visiting the recovery cancer patient made us more realize the patient’s realistic circumstance and the importance of health.
  • HSNU iGEM team and Mingdo iGEM team was helped by us to continue commitment to their Pro
  • We held iGEM Asia Conference for 27 teams to meetup, exchange ideas, make friends and cooperate mutually.
  • We promoted the communication and the cooperation among various rofessional fields such as synthetic biology, measurement technology, immunology, and medical science via the participation in iGEM and the accomplishment of the project.

  • Simultaneously detected the multiple antigens.
  • For more quantitative data and more application on precise measurements, we testified the function of GBP to bind on gold with the concept of Biosensor.
  • Enhanced the process yield in immobilization of antibodies on the medium gold surface.
  • The cost of using our E.cotectors is lower than using monoclonal antibodies targeted drugs directly on measuring antigens.

  • Offer a brand new direct method for doctors to determining the usage of monoclonal-antibody-targeted drugs.
  • Directly used the monoclonal-antibody-targeted-drugs to detect the corresponding antigen on the cancer cells.
  • Provided a direct, personalized and customized pre-diagnosis of targeted drugs treatment detection platform.
  • Offer the prescription of combination therapy to doctors.